Synthesis of platensimycin
Konrad Tiefenbacher1, Johann Mulzer
1Institut für Organische Chemie, Universität Wien, Währingerstrasse 38, 1090 Vienna, Austria.
Angewandte Chemie (International Ed. in English)
|March 11, 2008
Summary
Natural products are complex, but Streptomyces platensis metabolites yielded a potent antibiotic. This discovery challenges the trend favoring synthetic compounds in drug discovery.
Area of Science:
- Microbiology and Natural Product Chemistry
- Drug Discovery and Development
Background:
- Modern drug discovery predominantly utilizes antibodies and synthetic organic compounds, often overlooking natural products.
- Natural products are perceived as complex, scarce, and difficult to modify, diminishing their role in pharmaceutical research.
- A shift towards synthetic compounds has sidelined the exploration of natural product libraries.
Purpose of the Study:
- To investigate the potential of natural products as a source for novel therapeutic agents.
- To challenge the prevailing notion that natural products are too complex for drug discovery pipelines.
- To report the discovery of a promising antibiotic compound from a microbial source.
Main Methods:
- Classical screening of metabolites produced by Streptomyces platensis.
- Isolation and characterization of low-molecular-weight organic compounds.
- Evaluation of the antibiotic properties of the identified compounds.
Main Results:
- A low-molecular-weight organic compound with significant antibiotic activity was identified.
- The compound was isolated from the metabolites of Streptomyces platensis.
- The identified compound demonstrated remarkable efficacy, challenging existing drug discovery paradigms.
Conclusions:
- Natural products, specifically microbial metabolites, remain a valuable source for novel drug discovery.
- The identified compound from Streptomyces platensis represents a promising lead for antibiotic development.
- This finding underscores the importance of revisiting classical screening methods for natural product-based therapeutics.
Related Concept Videos
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:28Preparation of 1° Amines: Gabriel Synthesis
Direct alkylation is not a suitable method for synthesizing amines because it produces polyalkylated products. Gabriel synthesis is the most preferred method to exclusively make primary amines. The method uses phthalimide, which contains a protected form of nitrogen that participates in alkylation only once to predominantly give primary amines.
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...
Strong bases like NaOH or KOH deprotonate the phthalimide to form the corresponding anion, which acts as a nucleophile. Further, the anion attacks an...